Edition:
United States

Express Scripts Holding Co (ESRX.O)

ESRX.O on Nasdaq

61.55USD
10:06am EDT
Change (% chg)

$-0.27 (-0.44%)
Prev Close
$61.82
Open
$61.73
Day's High
$61.97
Day's Low
$61.30
Volume
346,326
Avg. Vol
3,494,772
52-wk High
$77.50
52-wk Low
$57.80

Chart for

About

Express Scripts Holding Company is a pharmacy benefit management (PBM) company. The Company is engaged in providing healthcare management and administration services to its clients, including managed care organizations, health insurers, third-party administrators, employers, union-sponsored benefit plans, workers' compensation... (more)

Overall

Beta: 0.88
Market Cap(Mil.): $35,704.08
Shares Outstanding(Mil.): 577.55
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 21.74 16.33
EPS (TTM): -- -- --
ROI: -- 11.98 14.66
ROE: -- 13.67 13.99

Express Scripts wins dismissal of lawsuit over Anthem ties

NEW YORK A federal judge has dismissed a lawsuit in which Express Scripts Holding Co shareholders accused the pharmacy benefits manager of inflating its share price by hiding its deteriorating relationship with its largest customer, Anthem Inc.

Aug 02 2017

Express Scripts wins dismissal of lawsuit over Anthem ties

NEW YORK A federal judge has dismissed a lawsuit in which Express Scripts Holding Co shareholders accused the pharmacy benefits manager of inflating its share price by hiding its deteriorating relationship with its largest customer, Anthem Inc .

Aug 02 2017

Express Scripts wins dismissal of lawsuit over Anthem ties

NEW YORK, Aug 2 A federal judge has dismissed a lawsuit in which Express Scripts Holding Co shareholders accused the pharmacy benefits manager of inflating its share price by hiding its deteriorating relationship with its largest customer, Anthem Inc.

Aug 02 2017

Express Scripts to cover Mylan's EpiPen, exclude rivals

NEW YORK Pharmacy benefit manager Express Scripts Holding Co said on Monday it would favor drugmaker Mylan Inc's versions of the EpiPen lifesaving allergy treatment over the allergy auto-injectors of other companies.

Jul 31 2017

Express Scripts to cover Mylan's EpiPen, exclude rivals

NEW YORK Pharmacy benefit manager Express Scripts Holding Co said on Monday it would favor drugmaker Mylan Inc's versions of the EpiPen lifesaving allergy treatment over the allergy auto-injectors of other companies.

Jul 31 2017

Express Scripts to cover Mylan's EpiPen, exclude rivals

NEW YORK, July 31 Pharmacy benefit manager Express Scripts Holding Co said on Monday it would favor drugmaker Mylan Inc's versions of the EpiPen lifesaving allergy treatment over the allergy auto-injectors of other companies.

Jul 31 2017

Express Scripts bearish on new Anthem contract

July 25 Pharmacy benefit manager Express Scripts Holding Co said on Tuesday that a new contract with biggest customer Anthem Inc would be on terms significantly less favorable for the company.

Jul 25 2017

BRIEF-Express Scripts Q2 earnings per share $1.37

* Q2 earnings per share view $1.71 -- Thomson Reuters I/B/E/S

Jul 25 2017

BRIEF-Jazz Pharmaceuticals says on June 28, its unit entered into pharmacy master services agreement with Express Scripts specialty distribution services

* Jazz Pharmaceuticals says on June 28, its unit entered into a pharmacy master services agreement with express scripts specialty distribution services

Jul 03 2017

BRIEF-Express Scripts elects Kathleen Mazzarella to board of directors

* Express Scripts elects Kathleen M. Mazzarella to board of directors Source text for Eikon: Further company coverage:

Jun 27 2017

Competitors

Earnings vs. Estimates